Article
A Comprehensive Multiomics Analysis Identified Ubiquilin 4 as a Promising Prognostic…
Journal of Oncology · 2021 · Jie Li, author Ye Tong, author Zhi Wang, author Yi Liu, author Xiaobo Dai, author Yuxi Zhu, author Kamaraj Sattu, Academic Editor
Key facts
| Title | A Comprehensive Multiomics Analysis Identified Ubiquilin 4 as a Promising Prognostic Biomarker of Immune-Related Therapy in Pan-Cancer |
|---|---|
| First author | Jie Li, author Ye Tong, author Zhi Wang, author Yi Liu, author Xiaobo Dai, author Yuxi Zhu, author Kamaraj Sattu, Academic Editor |
| Journal | Journal of Oncology |
| Published | Jul 14, 2021 |
| DOI | 10.1155/2021/7404927 |
| Devices mentioned | 201806 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1